10x, Stanford Cell-Tech Patents Survive Parse’s Dismissal Bid

Parse Biosciences Inc. failed to dismiss claims its single-cell gene expression products and test infringe six patents 10x Genomics Inc. either owns or licenses, as a Delaware federal judge allowed the case to proceed to trial.

Jurors will decide whether Parse’s Evercode Whole Transcriptome line of products and single-cell test infringe the patents and will determine their validity, Judge Joel H. Slomsky said in denying Parse’s dismissal motion in an opinion issued Wednesday in the US District Court for the District of Delaware. The trial is set to begin March 3.

• Slomsky found unresolved factual questions about whether Parse directly ...